JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bridges, A.
Right arrow Articles by Waskell, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bridges, A.
Right arrow Articles by Waskell, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 27, 17036-17049, July 3, 1998

Identification of the Binding Site on Cytochrome P450 2B4 for Cytochrome b5 and Cytochrome P450 Reductase

Angela BridgesDagger , Larry Gruenke, Yan-Tyng Changparallel , Ilya A. Vakser**, Gilda Loewparallel , and Lucy Waskell

From the  Department of Anesthesia and the Liver Center, University of California, San Francisco, California 94143, the Dagger  Department of Anesthesia, Veterans Affairs Medical Center, San Francisco, California 94121, the parallel  Molecular Research Institute, Palo Alto, California 94304, and the ** Department of Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425

A model of cytochrome P450 2B4, which was constructed by homology modeling with the four known crystal structures of the cytochromes P450 (Chang, T.-T., Stiffelman, O. B., Vakser, I. A., Loew, G. H., Bridges, A., and Waskell, L. (1997) Protein Eng. 10, 119-129), was used to select amino acids predicted, by computer docking studies and numerous previous biochemical and site-directed mutagenesis studies, to be involved in binding the heme domain of cytochrome b5. Twenty-four amino acid residues located on both the distal and the proximal surface of the molecule were chosen for mutagenesis. These 24 mutant proteins were expressed in Escherichia coli, purified, and characterized with respect to their ability to bind cytochrome b5 and support substrate oxidation. Seven mutants, R122A, R126A, R133A, F135A, M137A, K139A, and K433A, all on the proximal surface of cytochrome P450 2B4 near the heme ligand, were identified that exhibited decreased ability to bind cytochrome b5. All of the mutants except K433A are located in either the C or C* helices or their termini. In addition, these seven mutants and two additional mutants on the proximal surface of cytochrome P450, R422A and R443A, were shown to exhibit decreased binding to cytochrome P450 reductase. These studies indicate that the binding sites for cytochrome b5 and cytochrome P450 reductase are, as predicted, located on the proximal surface of cytochrome P450 2B4 and are partially overlapping but not identical.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
Y. Wada, M. Mitsuda, Y. Ishihara, M. Watanabe, M. Iwasaki, and S. Asahi
Important Amino Acid Residues that Confer CYP2C19 Selective Activity to CYP2C9
J. Biochem., September 1, 2008; 144(3): 323 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Oezguen, S. Kumar, A. Hindupur, W. Braun, B. K. Muralidhara, and J. R. Halpert
Identification and Analysis of Conserved Sequence Motifs in Cytochrome P450 Family 2: FUNCTIONAL AND STRUCTURAL ROLE OF A MOTIF 187RFDYKD192 IN CYP2B ENZYMES
J. Biol. Chem., August 1, 2008; 283(31): 21808 - 21816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhang, D. Hamdane, S.-C. Im, and L. Waskell
Cytochrome b5 Inhibits Electron Transfer from NADPH-Cytochrome P450 Reductase to Ferric Cytochrome P450 2B4
J. Biol. Chem., February 29, 2008; 283(9): 5217 - 5225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhang, S.-C. Im, and L. Waskell
Cytochrome b5 Increases the Rate of Product Formation by Cytochrome P450 2B4 and Competes with Cytochrome P450 Reductase for a Binding Site on Cytochrome P450 2B4
J. Biol. Chem., October 12, 2007; 282(41): 29766 - 29776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Mao, S. G. Rupasinghe, A. R. Zangerl, M. R. Berenbaum, and M. A. Schuler
Allelic Variation in the Depressaria pastinacella CYP6AB3 Protein Enhances Metabolism of Plant Allelochemicals by Altering a Proximal Surface Residue and Potential Interactions with Cytochrome P450 Reductase
J. Biol. Chem., April 6, 2007; 282(14): 10544 - 10552.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Kumar, H. Liu, and J. R. Halpert
Engineering of Cytochrome P450 3A4 for Enhanced Peroxide-Mediated Substrate Oxidation Using Directed Evolution and Site-Directed Mutagenesis
Drug Metab. Dispos., December 1, 2006; 34(12): 1958 - 1965.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Robins, J. Carlsson, M. Sunnerhagen, A. Wedell, and B. Persson
Molecular Model of Human CYP21 Based on Mammalian CYP2C5: Structural Features Correlate with Clinical Severity of Mutations Causing Congenital Adrenal Hyperplasia
Mol. Endocrinol., November 1, 2006; 20(11): 2946 - 2964.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Gao, C. E. Doneanu, S. A. Shaffer, E. T. Adman, D. R. Goodlett, and S. D. Nelson
Identification of the Interactions between Cytochrome P450 2E1 and Cytochrome b5 by Mass Spectrometry and Site-directed Mutagenesis
J. Biol. Chem., July 21, 2006; 281(29): 20404 - 20417.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Janner, A. V Pandey, P. E Mullis, and C. E Fluck
Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein.
Eur. J. Endocrinol., July 1, 2006; 155(1): 143 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Muralidhara, S. Negi, C. C. Chin, W. Braun, and J. R. Halpert
Conformational Flexibility of Mammalian Cytochrome P450 2B4 in Binding Imidazole Inhibitors with Different Ring Chemistry and Side Chains: SOLUTION THERMODYNAMICS AND MOLECULAR MODELING
J. Biol. Chem., March 24, 2006; 281(12): 8051 - 8061.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhao, M. A. White, B. K. Muralidhara, L. Sun, J. R. Halpert, and C. D. Stout
Structure of Microsomal Cytochrome P450 2B4 Complexed with the Antifungal Drug Bifonazole: INSIGHT INTO P450 CONFORMATIONAL PLASTICITY AND MEMBRANE INTERACTION
J. Biol. Chem., March 3, 2006; 281(9): 5973 - 5981.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. C. DeLozier, S.-C. Lee, S. J. Coulter, B. C. Goh, and J. A. Goldstein
Functional Characterization of Novel Allelic Variants of CYP2C9 Recently Discovered in Southeast Asians
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1085 - 1090.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M K Akhtar, S L Kelly, and M A Kaderbhai
Cytochrome b5 modulation of 17{alpha} hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis
J. Endocrinol., November 1, 2005; 187(2): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Ozalp, E. Szczesna-Skorupa, and B. Kemper
BIMOLECULAR FLUORESCENCE COMPLEMENTATION ANALYSIS OF CYTOCHROME P450 2C2, 2E1, AND NADPH-CYTOCHROME P450 REDUCTASE MOLECULAR INTERACTIONS IN LIVING CELLS
Drug Metab. Dispos., September 1, 2005; 33(9): 1382 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Kumar, D. R. Davydov, and J. R. Halpert
ROLE OF CYTOCHROME B5 IN MODULATING PEROXIDE-SUPPORTED CYP3A4 ACTIVITY: EVIDENCE FOR A CONFORMATIONAL TRANSITION AND CYTOCHROME P450 HETEROGENEITY
Drug Metab. Dispos., August 1, 2005; 33(8): 1131 - 1136.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. L. Miller
Minireview: Regulation of Steroidogenesis by Electron Transfer
Endocrinology, June 1, 2005; 146(6): 2544 - 2550.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
Z. Wen, J. Baudry, M. R. Berenbaum, and M. A. Schuler
Ile115Leu mutation in the SRS1 region of an insect cytochrome P450 (CYP6B1) compromises substrate turnover via changes in a predicted product release channel
Protein Eng. Des. Sel., April 1, 2005; 18(4): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Higashimoto, H. Sakamoto, S. Hayashi, M. Sugishima, K. Fukuyama, G. Palmer, and M. Noguchi
Involvement of NADP(H) in the Interaction between Heme Oxygenase-1 and Cytochrome P450 Reductase
J. Biol. Chem., January 7, 2005; 280(1): 729 - 737.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. B. Von Weymarn, C. Sridar, and P. F. Hollenberg
Identification of Amino Acid Residues Involved in the Inactivation of Cytochrome P450 2B1 by Two Acetylenic Compounds: The Role of Three Residues in Nonsubstrate Recognition Sites
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 71 - 79.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Clarke, S.-C. Im, A. Bidwai, and L. Waskell
The Role of the Length and Sequence of the Linker Domain of Cytochrome b5 in Stimulating Cytochrome P450 2B4 Catalysis
J. Biol. Chem., August 27, 2004; 279(35): 36809 - 36818.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. E. Scott, M. A. White, Y. A. He, E. F. Johnson, C. D. Stout, and J. R. Halpert
Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-A Resolution: INSIGHT INTO THE RANGE OF P450 CONFORMATIONS AND THE COORDINATION OF REDOX PARTNER BINDING
J. Biol. Chem., June 25, 2004; 279(26): 27294 - 27301.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Yamaguchi, K. K. Khan, Y. A. He, Y. Q. He, and J. R. Halpert
TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
Drug Metab. Dispos., January 1, 2004; 32(1): 155 - 161.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. F. Johnson
THE 2002 BERNARD B. BRODIE AWARD LECTURE: Deciphering Substrate Recognition by Drug-Metabolizing Cytochromes P450
Drug Metab. Dispos., December 1, 2003; 31(12): 1532 - 1540.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. E. Scott, Y. A. He, M. R. Wester, M. A. White, C. C. Chin, J. R. Halpert, E. F. Johnson, and C. D. Stout
From The Cover: An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution
PNAS, November 11, 2003; 100(23): 13196 - 13201.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
S. Kimura and T. Iyanagi
High-Level Expression of Porcine Liver Cytochrome P-450 Reductase Catalytic Domain in Escherichia coli by Modulating the Predicted Local Secondary Structure of mRNA
J. Biochem., September 1, 2003; 134(3): 403 - 413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Szczesna-Skorupa, B. Mallah, and B. Kemper
Fluorescence Resonance Energy Transfer Analysis of Cytochromes P450 2C2 and 2E1 Molecular Interactions in Living Cells
J. Biol. Chem., August 15, 2003; 278(33): 31269 - 31276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang and P. R. O. de Montellano
The Binding Sites on Human Heme Oxygenase-1 for Cytochrome P450 Reductase and Biliverdin Reductase
J. Biol. Chem., May 23, 2003; 278(22): 20069 - 20076.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Facchiano, K. Russo, A. M. Facchiano, F. De Marchis, F. Facchiano, D. Ribatti, M. S. Aguzzi, and M. C. Capogrossi
Identification of a Novel Domain of Fibroblast Growth Factor 2 Controlling Its Angiogenic Properties
J. Biol. Chem., February 28, 2003; 278(10): 8751 - 8760.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
A. Tovchigrechko, C. A. Wells, and I. A. Vakser
Docking of protein models
Protein Sci., August 1, 2002; 11(8): 1888 - 1896.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Y. H. Zhang, X. Wang, J. T. Wang, N. A. Compagnone, S. H. Mellon, J. L. Olson, H. S. Tenenhouse, W. L. Miller, and A. A. Portale
Dietary Phosphorus Transcriptionally Regulates 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Gene Expression in the Proximal Renal Tubule
Endocrinology, February 1, 2002; 143(2): 587 - 595.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. F. Cawley, S. Zhang, R. W. Kelley, and W. L. Backes
Evidence Supporting the Interaction of CYP2B4 and CYP1A2 in Microsomal Preparations
Drug Metab. Dispos., December 1, 2001; 29(12): 1529 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
A. Tovchigrechko and I. A. Vakser
How common is the funnel-like energy landscape in protein-protein interactions?
Protein Sci., August 1, 2001; 10(8): 1572 - 1583.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Schulz-Utermoehl, R. J. Mountfield, R. P. Bywater, K. Madsen, P. N. Jørgensen, and K. T. Hansen
Structure-Function Analysis of Human CYP3A4 Using a Specific Proinhibitory Antipeptide Antibody
Drug Metab. Dispos., July 1, 2000; 28(7): 718 - 725.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. A. Vakser, O. G. Matar, and C. F. Lam
A systematic study of low-resolution recognition in protein-protein complexes
PNAS, July 20, 1999; 96(15): 8477 - 8482.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. F. Sevrioukova, H. Li, H. Zhang, J. A. Peterson, and T. L. Poulos
Structure of a cytochrome P450-redox partner electron-transfer complex
PNAS, March 2, 1999; 96(5): 1863 - 1868.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yamazaki, T. Shimada, M. V. Martin, and F. P. Guengerich
Stimulation of Cytochrome P450 Reactions by Apo-cytochrome b5. EVIDENCE AGAINST TRANSFER OF HEME FROM CYTOCHROME P450 3A4 TO APO-CYTOCHROME b5 OR HEME OXYGENASE
J. Biol. Chem., August 10, 2001; 276(33): 30885 - 30891.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.